MacroGenics Inc (NASDAQ: MGNX) stock closed at $20.99 on 9/16/21 after a major decline of -23.8%. Moreover, this decline was accompanied by exceptionally high trading volume at 694% of normal. The stock has performed in line with the market over the last nine months and has declined -0.6% during the last week.
Current PriceTarget Research Rating
MGNX’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
MacroGenics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. MacroGenics has a poor Power Rating of 25 and a very low Appreciation Score of 9, producing the Lowest Value Trend Rating.
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.